Editorial: Perspective Needed on OTC or Behind the Counter

By George Anderson
Rachelle Cohen, an editorial writer for The Boston Herald, writes that things may be getting out-of-hand when politicians are requiring that boxes of Sudafed be sold from behind the counter while allowing pharmacists to sell Plan B, the emergency contraceptive, to women without a prescription.
Seven states to date have authorized pharmacists to distribute Plan B, aka The Morning After Pill, because the Food and Drug Administration has failed to act for nearly two years after its own independent board of scientific advisers recommended it be approved for over-the-counter sale.
Ms. Cohen questions why restricting the sale of Sudafed or other medications containing pseudoephedrine, the primary ingredient used to make methamphetamine, is necessary when other obviously apparent options exist. “God forbid we should just try busting the illegal labs – which, by the way, stink to high heaven and, therefore, ought not be difficult to find,” she writes.
Products containing pseudoephedrine are not the only ones that pose potential risks to consumers, writes Ms. Cohen. “The fact of the matter is there’s no end of dangerous stuff on drugstore shelves. An intentional overdose of Tylenol can be as deadly as a handful of prescription pills. Mouthwash can – and has been – abused by alcoholics.
“Where do we draw the line? And when does common sense play a role in this debate?”
Moderator’s Comment: Do you agree with Rachelle Cohen that common sense is often times set aside when it comes to
deciding what products get placed behind the counter or are sold OTC? What is your answer for coming up with a system that finds the right balance between commerce and the government’s
responsibility to protect its citizens?
– George Anderson – Moderator
Join the Discussion!
8 Comments on "Editorial: Perspective Needed on OTC or Behind the Counter"
You must be logged in to post a comment.
You must be logged in to post a comment.
Thank you, James! This is indeed a spurious debate. One thing has nothing to do with the other. Take each item on its merits. As a young reporter just out of college, I was chasing a story on a developer who had filled in wetlands for an apartment complex. When I finally got him on the phone, he baffled me with bs and told me that a young upstanding guy like me should be spending my time on more serious things, like ending the Vietnam war and all that. It was a full half hour after we hung up before I realized I’d been buffaloed. Now here’s a newspaper columnist trying the same ugly trick. Golly.
Pseudoephedrine, when used as an ingredient in methamphetamine production, is no longer an OTC drug – it’s a chemical ingredient. Keeping an eye on its large-scale purchase is prudent, because the people who make and traffic in meth are dangerous criminals.
Comparing this cautious new practice with the moral controversy over a form of birth control medication is spurious, in my book. There may be room for debate about the use of “morning-after” pills, but I am certain that nobody is buying them in quantity with the intention of converting them into a more dangerous, illegal substance.
I agree that there is a time and place for “supervision,” however I think we’re over the top when we ask already over-burdened pharmacists to police what consumers do with their meds or take time to dictate what a pharmacist can or cannot make available in their pharmacy. As a nation, we have much bigger issues to resolve when it comes to this country’s healthcare — I’d love to believe we will begin focusing on the real issues soon!
I agree with Rachel that the line needs to be drawn by common sense. Retailers can not be held accountable for the odd ways products are used and consumed.